I was reading up on the Pre IND process. In this piece it says that a briefing package is submitted ( done last week) 4 weeks before meeting with the FDA. From reading this, I gather Generex would meet with the FDA for a pre IND meeting in about three weeks.

https://www.oraclinical.com/resource/the-basi...d-meeting/